Migdal Insurance & Financial Holdings Ltd. Gilead Sciences, Inc. Transaction History

Migdal Insurance & Financial Holdings Ltd.

$6.18 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	BUY	$57.72 - $65.01 $15,930 - $17,942	276 Added 12.29%	2,521 $156,000
Q1 2022 May 02, 2022	SELL	$57.92 - $72.58 $271,123 - $339,746	-4,681 Reduced 67.59%	2,245 $134,000
Q4 2021 Feb 02, 2022	SELL	$64.88 - $73.64 $96,411 - $109,429	-1,486 Reduced 17.67%	6,926 $504,000
Q3 2021 Nov 16, 2021	SELL	$67.69 - $73.03 $38,786 - $41,846	-573 Reduced 6.38%	8,412 $588,000
Q2 2021 Aug 04, 2021	SELL	$63.47 - $69.35 $17,263 - $18,863	-272 Reduced 2.94%	8,985 $619,000
Q1 2021 May 04, 2021	BUY	$60.0 - $68.46 $482,340 - $550,349	8,039 Added 660.02%	9,257 $598,000
Q4 2020 Feb 08, 2021	BUY	$56.65 - $64.55 $12,349 - $14,071	218 Added 21.8%	1,218 $71,000
Q3 2020 Nov 05, 2020	SELL	$62.1 - $78.08 $101,036 - $127,036	-1,627 Reduced 61.93%	1,000 $62,000
Q2 2020 Aug 11, 2020	BUY	$72.34 - $84.0 $71,616 - $83,160	990 Added 60.48%	2,627 $200,000
Q1 2020 May 12, 2020	SELL	$62.63 - $80.22 $63,506 - $81,343	-1,014 Reduced 38.25%	1,637 $122,000
Q4 2019 Feb 13, 2020	BUY	$61.62 - $67.78 $10,352 - $11,387	168 Added 6.77%	2,651 $172,000
Q3 2019 Nov 12, 2019	BUY	$62.51 - $69.0 $53,633 - $59,202	858 Added 52.8%	2,483 $157,000
Q2 2019 Aug 08, 2019	SELL	$61.87 - $69.38 $298,151 - $334,342	-4,819 Reduced 74.78%	1,625 $110,000
Q1 2019 May 01, 2019	SELL	$62.53 - $70.05 $4,377 - $4,903	-70 Reduced 1.07%	6,444 $227,000
Q4 2018 Feb 13, 2019	SELL	$60.54 - $79.0 $1.13 Million - $1.48 Million	-18,706 Reduced 74.17%	6,514 $231,000
Q3 2018 Nov 08, 2018	BUY	$71.28 - $78.92 $611,083 - $676,581	8,573 Added 51.5%	25,220 $1.25 Million
Q2 2018 Aug 01, 2018	BUY	$64.88 - $75.68 $955,293 - $1.11 Million	14,724 Added 765.68%	16,647 $696,000
Q1 2018 May 02, 2018	BUY	$72.84 - $88.8 $35,181 - $42,890	483 Added 33.54%	1,923 $145,000
Q4 2017 Feb 06, 2018	SELL	$71.15 - $83.52 $1.55 Million - $1.81 Million	-21,723 Reduced 93.78%	1,440 $103,000
Q3 2017 Nov 06, 2017	BUY	$72.11 - $85.47 $1.52 Million - $1.8 Million	21,082 Added 1013.07%	23,163 $1.88 Million
Q2 2017 Aug 15, 2017	BUY	N/A	2,081	2,081 $147,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.1 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.07 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.71 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.56 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Migdal Insurance & Financial Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Migdal Insurance & Financial Holdings Ltd. with notifications on news.

Account